Share-based Payment Arrangement, Expense of Apyx Medical Corp from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Apyx Medical Corp quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Apyx Medical Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $530,000, a 47% decline year-over-year.
  • Apyx Medical Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2,339,000, a 43% decline year-over-year.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2024 was $4,013,000, a 22% decline from 2023.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2023 was $5,114,000, a 24% decline from 2022.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2022 was $6,697,000, a 32% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Apyx Medical Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,339,000 $530,000 -$467,000 -47% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $2,806,000 $520,000 -$530,000 -50% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $3,336,000 $451,000 -$677,000 -60% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,013,000 $838,000 -$76,000 -8.3% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 $4,089,000 $997,000 -$354,000 -26% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $4,443,000 $1,050,000 -$432,000 -29% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $4,875,000 $1,128,000 -$239,000 -17% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $5,114,000 $914,000 -$727,000 -44% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $5,841,000 $1,351,000 -$341,000 -20% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $6,182,000 $1,482,000 -$232,000 -14% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $6,414,000 $1,367,000 -$283,000 -17% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $6,697,000 $1,641,000 +$300,000 +22% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $6,397,000 $1,692,000 +$508,000 +43% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $5,889,000 $1,714,000 +$345,000 +25% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $5,544,000 $1,650,000 +$456,000 +38% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $5,088,000 $1,341,000 +$340,000 +34% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $4,748,000 $1,184,000 +$121,000 +11% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $4,627,000 $1,369,000 +$272,000 +25% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $4,355,000 $1,194,000 +$145,000 +14% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $4,210,000 $1,001,000 +$3,970,000 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $240,000 $1,063,000 -$2,146,000 -67% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $2,386,000 $1,097,000 -$1,049,000 -49% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $3,435,000 $1,049,000 -$146,000 -12% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q4 2019 $3,581,000 $2,969,000 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $3,209,000 +$2,720,000 +556% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $2,146,000 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $1,195,000 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q3 2018 $489,000 +$298,000 +156% 01 Jul 2018 30 Sep 2018 10-Q 15 Nov 2019 2019 Q3
Q4 2017 $871,000 $339,000 +$63,000 +23% 01 Oct 2017 31 Dec 2017 10-K 31 Mar 2020 2019 FY
Q3 2017 $808,000 $191,000 +$18,000 +10% 01 Jul 2017 30 Sep 2017 10-Q 03 Nov 2017 2017 Q3
Q2 2017 $790,000 $182,000 -$2,000 -1.1% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 $792,000 $159,000 -$17,000 -9.7% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $809,000 $276,000 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
Q3 2016 $173,000 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017 2017 Q3
Q2 2016 $184,000 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017 2017 Q2
Q1 2016 $176,000 -$118,399,000 -100% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2016 2016 Q1
Q1 2015 $118,575,000 +$36,575,000 +45% 01 Jan 2015 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q3 2014 $127,612 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q1 2014 $82,000,000 +$81,950,000 +163900% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q1 2013 $50,000 01 Jan 2013 31 Mar 2013 10-Q 15 May 2013 2013 Q1

Apyx Medical Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $4,013,000 -$1,101,000 -22% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $5,114,000 -$1,583,000 -24% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $6,697,000 +$1,609,000 +32% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $5,088,000 +$878,000 +21% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $4,210,000 +$629,000 +18% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $3,581,000 +$1,357,000 +61% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $2,224,000 +$1,353,000 +155% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2020 2019 FY
2017 $871,000 +$62,000 +7.7% 01 Jan 2017 31 Dec 2017 10-K 31 Mar 2020 2019 FY
2016 $809,000 +$241,000 +42% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
2015 $568,000 +$180,000 +46% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
2014 $388,000 -$118,000 -23% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $506,000 +$345,000 +214% 01 Jan 2013 31 Dec 2013 10-K 18 Mar 2016 2015 FY
2012 $161,000 +$29,000 +22% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $132,000 -$31,000 -19% 01 Jan 2011 31 Dec 2011 10-K/A 08 May 2014 2013 FY
2010 $163,000 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.